TELA Bio, Inc.
TELA
$1.27
-$0.03-2.31%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -40.77M | -43.44M | -37.84M | -41.52M | -42.11M |
| Total Depreciation and Amortization | 1.07M | 1.05M | 1.01M | 907.00K | 862.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.56M | 7.74M | 103.00K | -575.00K | -641.00K |
| Change in Net Operating Assets | -2.00M | -2.28M | -4.87M | -3.92M | -1.21M |
| Cash from Operations | -34.14M | -36.94M | -41.60M | -45.12M | -43.10M |
| Capital Expenditure | -532.00K | -717.00K | -989.00K | -930.00K | -942.00K |
| Sale of Property, Plant, and Equipment | 5.44M | 5.44M | 5.44M | 12.00K | 12.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.88M | -4.83M | 0.00 | 5.37M | 5.37M |
| Cash from Investing | 30.00K | -107.00K | 4.45M | 4.45M | 4.44M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 43.10M | 43.10M | 43.43M | 533.00K | 492.00K |
| Repurchase of Common Stock | -210.00K | -218.00K | -369.00K | -362.00K | -348.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 42.89M | 42.89M | 43.06M | 171.00K | 144.00K |
| Foreign Exchange rate Adjustments | -292.00K | -152.00K | 28.00K | -140.00K | 15.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.48M | 5.69M | 5.94M | -40.64M | -38.51M |